This article is a correction to:
Association between amoxicillin administration and outcomes in critically ill patients with acute kidney injury
Xinyao Luo1†
Baihai Su- 1Department of Nephrology, Kidney Research Institute, West China Hospital, Sichuan University, Chengdu, China
- 2Department of Intensive Care Medicine, West China Hospital, Sichuan University, Chengdu, China
A Corrigendum on
Association between amoxicillin administration and outcomes in critically ill patients with acute kidney injury
by Luo X, Zhou W, Wan D, Peng J, Liao R and Su B (2024). Front. Pharmacol. 15:1409654. doi: 10.3389/fphar.2024.1409654
In the published article, there was an error in Figure 2 as published. Figure 2 contains superfluous elements. The corrected Figure 2 and its caption appear below.
Figure 2
Figure 2. The association between amoxicillin administration and clinical outcomes in patients with AKI. (A) Association between amoxicillin administration and clinical outcomes. Four different methods were used to address the associations: 1) univariable Cox regression, 2) multivariable Cox regression, 3) propensity score matching, and 4) inverse propensity weighted modeling. (B) Kaplan‒Meier survival curves of the amoxicillin group and non-amoxicillin group after PSM for 30-day mortality. (C) Kaplan‒Meier survival curves of the amoxicillin group and non-amoxicillin group after PSM for 30-day mortality. Notes: HRs (95% CIs) were derived from Cox proportional hazards regression models. Covariates were adjusted as in the model II. The MDs (95% CIs) were derived from linear regression models. Covariates were adjusted as in the model II. Abbreviations: HR, hazard ratio; MD mean difference; PSM, propensity score matching; IPTW, inverse probability of treatment weighting; ICU, intensive care unit.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: acute kidney injury, amoxicillin, intensive care unit, mortality, acute kidney disease
Citation: Luo X, Zhou W, Wan D, Peng J, Liao R and Su B (2024) Corrigendum: Association between amoxicillin administration and outcomes in critically ill patients with acute kidney injury. Front. Pharmacol. 15:1468612. doi: 10.3389/fphar.2024.1468612
Received: 22 July 2024; Accepted: 14 October 2024;
Published: 05 November 2024.
Edited and reviewed by:
Giuseppe Remuzzi, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, ItalyCopyright © 2024 Luo, Zhou, Wan, Peng, Liao and Su. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Baihai Su, subaihai@scu.edu.cn; Ruoxi Liao, lrx-wch@foxmail.com
†These authors have contributed equally to this work and share first authorship